Having trouble viewing this message? View this email in a browser.
Share Share
Tweet Tweet
Forward Forward

Cold Weather Alert!

Did you know cold weather can impact asthma? Much of the U.S. is experiencing cold temperatures, so it's important to know how to prevent asthma symptoms during winter weather. Follow our tips to help you manage your asthma even when the temperature dips.
A picture of a woman in winter clothing that says: Cold air triggers asthma. Cover your mouth and nose with a scarf or mask.

Going to College With Asthma

Do you have a first-year college student with asthma who has headed back to the dorm for their spring semester? Give them a refresher on asthma self-management with our videos for college students with asthma. Our videos include:
  • 10 things college students forget when they move to college
  • What to do if they get sick at school
  • Health insurance terms every college student should know

A Look Back at Asthma and Allergy Advocacy in 2021

Our community is very active in grassroots advocacy. Together, we saw some great strides in asthma and allergy policy in 2021 thanks to your actions and support. Read our recap of the past year in asthma and allergy advocacy, along with some of our advocacy goals for 2022. 

A picture of infographic about how to shop for an asthma and allergy friendly pillow

Sleeping With the Enemy: Protect Your Face From Dust Mites and Mold

Is it time for a new pillow? Old pillows can harbor dust mites, bacteria, mold, and other fungi. After two years, 10% of the weight of your pillow can be from dead dust mites and their droppings. Learn what makes a pillow or pillow cover CERTIFIED asthma & allergy friendly® so you can rest easy in a healthier sleeping environment.


Clinical Trial Opportunity

AAFA is sharing an opportunity to participate in a clinical research study for people with allergic bronchopulmonary aspergillosis (ABPA).

Researchers are now recruiting participants for the LIBERTY-ABPA AIRED study. This is clinical research study to test whether an investigational medication helps adults and adolescents aged 12 years and older with ABPA to decrease episodes of severe breathing difficulties. The study will also evaluate the long-term safety of the investigational medication.

The LIBERTY‑ABPA AIRED study consists of a 4‑week screening period to determine eligibility, followed by a treatment period and a safety follow‑up period. The treatment period lasts approximately 52 weeks, with a safety follow‑up within 12 weeks after treatment ends.

Peak Flow App Study

Researchers are looking for people with asthma to help them test a peak flow meter app. The purpose of this study is to develop a way to help people manage their asthma by tracking their peak flow reading through their smartphones. They are looking for adults with asthma in the United States who use an iPhone 11 or newer. If you qualify, you will get a peak flow meter for testing and reward when you complete the study. Participation is 100% remote. Learn more.


FDA Approves TEZSPIRE™ to Treat Severe Asthma for People Ages 12 and Older

The FDA recently approved TEZSPIRE™ (tezepelumab-ekko), a biologic medicine, for add-on maintenance to treatment of asthma in people ages 12 years and older with severe asthma. Read the press release to learn more.

New Treatment for People Ages 12 and Older With Moderate-to-Severe Atopic Dermatitis

The FDA approved RINVOQ® (upadacitinib) for the treatment of moderate-to-severe atopic dermatitis (AD) in people ages 12 and older who do not respond to previous treatment and whose AD is not well-controlled with other pills or injections. Read the press release to learn more.

Update: COVID-19 Vaccine Info

The CDC now recommends that people ages 12 and older get a COVID-19 booster shot. They have also updated recommendations for additional primary shots for some children who are immunocompromised. See the updates on our blog.

Johnson Controls and AAFA to Raise Awareness on Indoor Air Quality and Health

Johnson Controls and AAFA will be collaborating to improve health outcomes for families managing asthma and allergies by raising awareness of the connection between indoor air quality and health. Read Johnson Controls' press release to learn more.


You’re Invited: Live Webinar on EoE

Do you or your child have eosinophilic esophagitis (EoE)? Learn about managing EoE during a one-hour live webinar called, “Eating Without Pain: Partnership for Effective Management of EoE,” on Friday, Feb. 4 at 3 p.m. ET.
An expert panel will discuss the signs and symptoms of EoE in babies, children, and adults that should prompt testing for EoE. They will also explain the various kinds of treatments and medications. You will learn how to take a more active role in treatment planning, find resources for social and financial support, and find answers to your pressing questions. Register today!

Submit your questions before the event. If you can’t watch the session live, you will be able to watch later on demand, so be sure to register. We hope to see you there!


Asthma and allergies can be daunting. But they can be managed with the right treatment, resources, and support. AAFA is here to help people with asthma and allergies and their caregivers understand and manage their conditions and move to a place of confidence. We provide a vital lifeline through support, advocacy, education, and research.
You are why we can fulfill our mission to save lives and reduce the burden of asthma and allergies. We need your help to be able to continue our work. Please consider supporting AAFA and making a difference in the lives of people managing asthma and allergies.

Did You Miss Our Last Issue?

If you didn't get a chance to read our December 2021 issue, check it out to learn more about preventing a flu/COVID-19 "twindemic," joining the AAFA support community, improving your indoor air quality in your attic or basement, and more.

Thank you for your continued support.

Follow Follow
Twitter Twitter
Instagram Instagram
YouTube YouTube
Disclaimer: This newsletter is provided to you as a member and subscriber benefit and your use of it is in accordance with our website's terms of service.

Asthma and Allergy Foundation of America makes no representation, whatsoever, for the contents that may be contained in any of the sponsors or advertisers in this newsletter or the quality of any products, information, or other materials displayed, purchased or obtained by you as a result of an offer in connection with any advertisement. Please follow the instructions at the bottom of the newsletter to unsubscribe if you no longer wish to be on our newsletter mailing list. This newsletter is sent to all newsletter subscribers, registered members and donors of Asthma and Allergy Foundation of America.

Copyright © 2022 Asthma and Allergy Foundation of America, All rights reserved. ISSN 1939-8166.